Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Public ClinicalTrials.gov record NCT07195695. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Beamion LUNG-3: A Randomized, Controlled, Multi-center Trial Evaluating Zongertinib as an Adjuvant Monotherapy Compared With Standard of Care in Patients With Early-stage, Resectable Non-small Cell Lung Cancer (Stage II-IIIB) Harboring Tyrosine Kinase Domain Activating HER2 Mutations
Study identification
- NCT ID
- NCT07195695
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- Atezolizumab Drug
- Durvalumab Drug
- Nivolumab Drug
- Pembrolizumab Drug
- Zongertinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 15, 2026
- Primary completion
- Feb 25, 2032
- Completion
- Sep 1, 2036
- Last update posted
- May 5, 2026
2026 – 2036
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ClinRé 001-022 (Premier Cancer Care and Infusion Center) | Fresno | California | 93710 | Recruiting |
| OPN Healthcare, Inc. | Glendale | California | 91203 | Recruiting |
| University of California Irvine | Irvine | California | 92697 | Not yet recruiting |
| Sutter Health | Roseville | California | 95661 | Not yet recruiting |
| University of California San Francisco | San Francisco | California | 94143 | Not yet recruiting |
| Sarcoma Oncology Center | Santa Monica | California | 90403 | Not yet recruiting |
| University of California Los Angeles | Santa Monica | California | 90404 | Recruiting |
| Northern California Kaiser Permanente | Vallejo | California | 94589 | Not yet recruiting |
| George Washington University Cancer Center | Washington D.C. | District of Columbia | 20037 | Not yet recruiting |
| Mid Florida Hematology and Oncology Center | Orange City | Florida | 32763 | Recruiting |
| Piedmont Cancer Institute | Atlanta | Georgia | 30318 | Recruiting |
| Northwest Georgia Oncology Centers | Marietta | Georgia | 30060 | Recruiting |
| Saint Alphonsus Regional Medical Center - Boise | Boise | Idaho | 83706 | Not yet recruiting |
| Northwestern University | Chicago | Illinois | 60611 | Not yet recruiting |
| University of Illinois Hospital and Health Sciences System | Chicago | Illinois | 60612 | Recruiting |
| Duly Health and Care - Lisle | Lisle | Illinois | 60532 | Not yet recruiting |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| Cancer Care Specialists | Reno | Nevada | 89511 | Recruiting |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | Not yet recruiting |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | New York | New York | 10016 | Recruiting |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | Recruiting |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | Not yet recruiting |
| Durham VA Health Care System | Durham | North Carolina | 27705 | Not yet recruiting |
| Providence Cancer Institute | Portland | Oregon | 97213 | Recruiting |
| Hendrick Health | Abilene | Texas | 79601 | Recruiting |
| Community Cancer Trials of Utah | Ogden | Utah | 84405 | Recruiting |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 170 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07195695, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07195695 live on ClinicalTrials.gov.